[1]GRGACIC E V, ANDERSON D A. Virus-like particles: passport to immune recognition [J]. Methods, 2006, 40(1):60-65.
[2]CHACKERIAN B. Virus-like particles: flexible platforms for vaccine development [J]. Expert Rev Vaccines, 2007, 6(3):381-390.
[3]PALIARD X, LIU Y, WAGNER R, et al. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques [J]. AIDS Res Hum Retroviruses, 2000, 16(3):273-282.
[4]WIN S J, WARD V K, DUNBAR P R, et al. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway [J]. Immunol Cell Biol, 2011, 89(6): 681-688.
[5]范京惠,左玉柱,唐丽杰,等.含 CSFV T 细胞表位的猪细小病毒样颗粒的表达及小鼠免疫试验[J].农业生物技术学报,2007, 15(5): 746-751.
FAN J H, ZUO Y Z, TANG L J, et al. Expression of porcine parvovirus-like particles carrying a CSFV T cell epitope and its immunization on Mice[J]. Journal of Agricultural Biotechnology, 2007, 15(5): 746-751. (in Chinese)
[6]申小强,王超,左玉柱,等.猪细小病毒样颗粒在树突状细胞中定位的研究[J].河北农业大学学报, 2014, 37(6): 95-100.
SHEN X Q, WANG C, ZUO Y Z, et al. Location study of recombinant parvovirus-like particles in dendritic cells[J]. Journal of Agricultural University of Hebei, 2014, 37(6): 95-100. (in Chinese)
[7]邸晶美,左玉柱,申小强,等.不同药物对树突状细胞捕获猪细小病毒样颗粒的影响[J]. 中国兽医学报,2016, 36(7): 1157-1162.
DI J M, ZUO Y Z, SHEN X Q, et al. Influence of different drugs on dendritic cells endocytic uptake recombinant parvovirus-like particles[J]. Chinese Journal Veterinary Science, 2016, 36(7): 1157-1162. (in Chinese)
[8]申小强,左玉柱,邸晶美,等.不同内吞方式中的关键因子抗体对树突状细胞捕获猪细小病毒样颗粒的影响[J].畜牧兽医学报,2016, 47(9):1924-1930.
SHEN X Q, ZUO Y Z, DI J M, et al. The influence of antibodies against key factors of different endocytic pathways on dendritic cells uptake recombinant parvovirus-like particles[J]. Acta Veterinaria et Zootechnica Sinica, 2016, 47(9):1924-1930. (in Chinese)
[9]BACHMANN M F, JENNINGS G T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns [J]. Nat Rev Immunol, 2010, 10(11): 787-796.
[10]XIANG S D, SCHOLZEN A, MINIGO G, et al. Pathogen recognition and development of particulate vaccines: does size matter[J]. Methods, 2006, 40(1): 1-9.
[11]KOVACSOVICS, BANKOWSKI M, ROCK K L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules [J]. Science, 1995, 267(5195):243-246.
[12]GRGACIC E V, ANDERSON D A. Virus-like particles: passport to immune recognition [J]. Methods, 2006,40(1): 60-65.
[13]LUDWIG C, WAGNER R. Virus-like particles-universal molecular toolboxes [J]. Curr Opin Biotechnol, 2007, 18(6):537-545.
[14]GEDVILAITE A, DOM D C, SASNAUSKAS K, et al. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells [J]. Virology, 2006, 354(2): 252-260.
[15]MORÓN V G, RUEDA P, SEDLIK C, et al. In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway [J]. J Immunol, 2003, 171(5):2242-2250.
[16]BOISGERAULT F, RUEDA P, SUN C M, et al. Cross-priming of T cell responses by synthetic microspheres carrying a CD8+ T cell epitope requires an adjuvant signal [J]. J Immounol, 2005, 174(6): 3432-3439.
[17]AMIGORENA S, SAVINA A. Intracellular mechanisms of antigen cross-presentation in dendritic cells [J]. Curr Opin Immunol, 2010, 22(1):109-117.
[18]KASTURI S P, PULENDRAN B. Cross-presentation: avoiding trafficking chaos [J]. Nat Immunol, 2008, 9(5):461-463.
[19]BURGDORF S, SCHO C, KAUTZ A, et al. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation [J]. Nat Immunol, 2008, 9(5):558-566.
[20]DI P T, CHATTERJEE B, SMED-SORENSEN A, et al. Direct proteasome-independent cross-presentation of viral Ag by plasmacytoid dendritic cells on major histocompatibility complex class I [J]. Nat Immunol, 2008, 9(5): 551-557.
[21]SHEN L, SIGAL L J, BOES M, et al. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo[J]. Immunity, 2004, 21(2):155-165.
[22]GUERMONPREZ P, SAVEANU L, KLEIJMEER M, et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells [J]. Nature, 2003, 425(6956):397-402.
[23]MONU N, TROMBETTA E S. Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules [J]. Curr Opin Immunol, 2007, 19(1):66-72.
[24]STOBER D, TROBONJACA Z, REIMANN J, et al. Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells [J]. Eur J Immunol, 2002, 32(4):1099-1108.
[25]SINNATHAMBY G, EISENLOHR L C. Presentation by Recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification [J]. J Immunol, 2003, 170(7):3504-3513. |